Global Patent Index - EP 0610345 B1

EP 0610345 B1 2000-07-12 - COMBINED CELLULAR AND IMMUNOSUPPRESSIVE THERAPIES

Title (en)

COMBINED CELLULAR AND IMMUNOSUPPRESSIVE THERAPIES

Title (de)

KOMBINIERTE ZELLULÄRE UND IMMUNSUPPRESSIVE THERAPIEN

Title (fr)

THERAPIES CELLULAIRES ET IMMUNO-SUPPRESSIVES COMBINEES

Publication

EP 0610345 B1 (EN)

Application

EP 92922624 A

Priority

  • US 9208969 W
  • US 78107591 A

Abstract (en)

[origin: US5670148A] Novel regimens are provided for administering foreign genetically modified allogeneic cells to a host by combining the administration of the cells with a reduced regimen of an immunosuppressive agent. Particularly, cells having a reduced level of Class I MHC antigens may be employed in a variety of cellular therapy situations, where foreign cells are engrafted to treat diseased states.

IPC 1-7 (main, further and additional classification)

A61K 35/12; A61K 35/36

IPC 8 full level (invention and additional information)

A61K 38/00 (2006.01); A61K 35/12 (2006.01); A61K 35/36 (2015.01); A61K 38/13 (2006.01); A61K 39/00 (2006.01); A61P 37/06 (2006.01)

CPC (invention and additional information)

A61K 39/001 (2013.01); A61K 31/436 (2013.01); A61K 35/36 (2013.01); A61K 38/13 (2013.01); C12N 2510/00 (2013.01)

Combination set (CPC)

  1. A61K 35/36 + A61K 2300/00
  2. A61K 38/13 + A61K 2300/00
  3. A61K 31/436 + A61K 2300/00

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL SE

DOCDB simple family

US 5670148 A 19970923; AT 194494 T 20000715; AU 2883192 A 19930521; CA 2121487 A1 19930429; DE 69231250 D1 20000817; DE 69231250 T2 20010315; DK 0610345 T3 20001023; EP 0610345 A1 19940817; EP 0610345 A4 19970115; EP 0610345 B1 20000712; ES 2150424 T3 20001201; GR 3034510 T3 20001229; JP H07500343 A 19950112; WO 9307887 A1 19930429